K-numberK252920
Device nameELEOS™ Limb Salvage System with NanoCept® Technology
ApplicantOnkos Surgical, Inc.
Product codeQZZ
Device classClass II
Decision dateOct 15, 2025
DecisionSubstantially Equivalent
Regulation888.3900
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

The ELEOS™ Limb Salvage System with NanoCept® Technology is a reconstruction implant system for resection and replacement of proximal femur, femoral shaft, total femur, distal femur, and proximal tibia in skeletally mature patients with degenerative joint disease, trauma, or oncologic conditions. The device includes an antibacterial coating to reduce bacterial contamination on the device surface prior to implantation from the operating room environment.

Technological characteristics

The subject device applies a covalently bound quaternary ammonium compound (MDPB) antibacterial coating to cobalt-chromium proximal tibia components that were previously cleared without coating. The coating reduces contamination on the device surface prior to implantation by killing bacteria external to the patient and does not act within or on the patient's body.

Test standards cited

Not stated in this summary.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →